WO2000073454A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
US20030069403A1
(en)
|
1997-06-16 |
2003-04-10 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
ES2629442T3
(en)
|
1998-06-01 |
2017-08-09 |
Agensys, Inc. |
New transmembrane serpentine antigens expressed in human cancers and uses thereof
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US7264801B2
(en)
|
1998-08-11 |
2007-09-04 |
Genentech, Inc. |
EG-VEGF nucleic acids and polypeptides and method of use
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
US20030003507A1
(en)
|
1999-06-02 |
2003-01-02 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
CA2359132A1
(en)
|
1999-01-15 |
2000-07-20 |
Roxanne D. Duan |
Bone marrow-specific protein
|
US7034132B2
(en)
|
2001-06-04 |
2006-04-25 |
Anderson David W |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
AU776341B2
(en)
*
|
1999-08-19 |
2004-09-02 |
Kurokawa, Kiyoshi |
Meg-1 protein
|
US20020042062A1
(en)
|
1999-09-24 |
2002-04-11 |
Mark Stearns |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
US7790861B2
(en)
*
|
1999-09-24 |
2010-09-07 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
CA2389724A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Human Genome Sciences, Inc. |
28 human secreted proteins
|
AU2288601A
(en)
|
1999-12-23 |
2001-07-03 |
Millennium Pharmaceuticals, Inc. |
P2Y12 receptor
|
WO2003048326A2
(en)
*
|
2001-12-03 |
2003-06-12 |
Nuvelo, Inc. |
Methods and materials relating to novel polypeptides and polynucleotides
|
AU781508B2
(en)
|
2000-02-11 |
2005-05-26 |
Glycozym Aps |
UDP-galactose: beta-D-galactose-R 4-alpha-D-galactosyltransferase, alpha4Gal-T1
|
JP4342069B2
(en)
*
|
2000-02-14 |
2009-10-14 |
生化学工業株式会社 |
α1,4-Galactosyltransferase and DNA encoding the same
|
AU6802801A
(en)
*
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1698697A3
(en)
*
|
2000-03-24 |
2006-09-13 |
Takeda Pharmaceutical Company Limited |
SSD-containing protein, process for producing the same and use thereof
|
JP2003530124A
(en)
*
|
2000-04-05 |
2003-10-14 |
麒麟麦酒株式会社 |
Methods and materials for novel stem cell growth factor-like polypeptides and polynucleotides
|
AU2001268967A1
(en)
*
|
2000-04-18 |
2001-10-30 |
Bayer Aktiengesellschaft |
Regulation of human epithin-like serine protease
|
EP1280917A2
(en)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
US20030092035A1
(en)
|
2000-05-04 |
2003-05-15 |
Anderson David J. |
Pain signaling molecules
|
US7510845B2
(en)
|
2000-05-04 |
2009-03-31 |
California Institute Of Technology |
Assay employing G protein-coupled receptor expressed in dorsal root ganglia
|
JP2003532416A
(en)
*
|
2000-05-09 |
2003-11-05 |
バイエル アクチェンゲゼルシャフト |
Endothelial differentiation gene 6-like G protein-coupled receptor
|
WO2001092494A2
(en)
*
|
2000-05-26 |
2001-12-06 |
Millennium Pharmaceuticals, Inc. |
50250, a human lipase and uses thereof
|
AU2001268570A1
(en)
*
|
2000-06-16 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
33358, a novel human ankyrin family member and uses thereof
|
WO2001098354A2
(en)
*
|
2000-06-21 |
2001-12-27 |
Incyte Genomics, Inc. |
Human receptors
|
AU7018801A
(en)
*
|
2000-06-26 |
2002-01-08 |
Millennium Pharm Inc |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
AU2001281933A1
(en)
*
|
2000-06-30 |
2002-01-14 |
Ingenium Pharmaceuticals Ag |
Human g protein-coupled receptor igpcr17, and uses therof
|
WO2002006312A2
(en)
*
|
2000-07-13 |
2002-01-24 |
Novartis Ag |
Disease-associated gene
|
AU2001278488A1
(en)
*
|
2000-07-25 |
2002-02-05 |
Bayer Aktiengesellschaft |
Regulation of human matriptase-like serine protease
|
EP1307557A2
(en)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
WO2003024276A1
(en)
*
|
2000-08-02 |
2003-03-27 |
Millennium Pharmaceuticals,Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
DE60121346T8
(en)
*
|
2000-08-04 |
2007-12-13 |
Ludwig Institute For Cancer Research |
Suppressor gene
|
EP1688496A3
(en)
*
|
2000-08-14 |
2006-08-16 |
Actimis Pharmaceuticals, Inc., |
Regulation of human P2Y1-like G protein-coupled receptor
|
ES2258553T3
(en)
*
|
2000-08-14 |
2006-09-01 |
Actimis Pharmaceuticals, Inc. |
REGULATION OF THE RECEPTOR COUPLED TO HUMAN PROTEIN G TYPE P2Y1.
|
AU2001284902A1
(en)
*
|
2000-08-15 |
2002-02-25 |
Zymogenetics Inc. |
Human adenosine deaminase
|
AU2001285102A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
US20030224396A1
(en)
*
|
2000-08-30 |
2003-12-04 |
Yonghong Xiao |
Regulation of human aminotransferase-like enzyme
|
US20030166300A1
(en)
*
|
2000-08-30 |
2003-09-04 |
Tang Y. Tom |
Growth-related inflammatory and immune response protein
|
WO2002022777A2
(en)
*
|
2000-09-15 |
2002-03-21 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
|
US7754435B2
(en)
*
|
2000-09-21 |
2010-07-13 |
Philadelphia Health And Education Corporation |
Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
|
CA2423677A1
(en)
*
|
2000-10-04 |
2002-04-11 |
Curagen Corporation |
Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
|
WO2002031126A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
WO2002095032A2
(en)
|
2000-10-19 |
2002-11-28 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions of human proteins and uses thereof.
|
US20020115610A1
(en)
|
2000-11-03 |
2002-08-22 |
Qun-Yong Zhou |
Prokineticin polypeptides, related compositions and methods
|
US20030009017A1
(en)
*
|
2000-11-08 |
2003-01-09 |
Leiby Kevin R. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
WO2002038743A2
(en)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
DE60142984D1
(en)
*
|
2000-11-09 |
2010-10-14 |
Univ Virginia |
HUMAN SPECIMENS SERIN / THREONINE KINASE
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
EP1387888A2
(en)
*
|
2000-12-21 |
2004-02-11 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US20030148920A1
(en)
*
|
2000-12-27 |
2003-08-07 |
Steven Rosen |
Sulfatases and methods of use thereof
|
WO2002053719A2
(en)
*
|
2001-01-04 |
2002-07-11 |
Incyte Genomics, Inc. |
Cytoskeleton-associated proteins
|
WO2002064792A2
(en)
*
|
2001-01-05 |
2002-08-22 |
Incyte Genomics, Inc. |
Molecules for disease detection and treatment
|
US6319679B1
(en)
*
|
2001-01-26 |
2001-11-20 |
Board Of Regents, The University Of Texas System |
PAS kinase
|
US20020115136A1
(en)
*
|
2001-02-07 |
2002-08-22 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
WO2002064777A2
(en)
*
|
2001-02-14 |
2002-08-22 |
Axaron Bioscience Ag |
Proteins 7b6 and 11b4 and dna sequences encoding the same
|
CA2440272A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Incyte Genomics, Inc. |
Nucleic acid-associated proteins
|
US20030044813A1
(en)
*
|
2001-03-30 |
2003-03-06 |
Old Lloyd J. |
Cancer-testis antigens
|
US20020146795A1
(en)
*
|
2001-04-02 |
2002-10-10 |
Shiaoping Zhu |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
US7927597B2
(en)
*
|
2001-04-10 |
2011-04-19 |
Agensys, Inc. |
Methods to inhibit cell growth
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US6962811B2
(en)
|
2001-05-09 |
2005-11-08 |
Millennium Pharmaceuticals, Inc. |
14715, a human fringe family member nucleic acids and uses therefor
|
JP4231778B2
(en)
|
2001-05-29 |
2009-03-04 |
株式会社ヒューマンセルシステムズ |
Testicular carnitine transporter and its gene
|
EP1456650B1
(en)
|
2001-06-05 |
2010-10-06 |
Exelixis, Inc. |
Gfats as modifiers of the p53 pathway and methods of use
|
ES2372321T3
(en)
*
|
2001-06-20 |
2012-01-18 |
Genentech, Inc. |
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF A LUNG TUMOR.
|
AU2002319261A1
(en)
*
|
2001-06-25 |
2003-01-08 |
Bayer Aktiengesellschaft |
Regulation of human serine/threonine protein kinase nek3
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ES2532757T3
(en)
|
2001-09-06 |
2015-03-31 |
Agensys, Inc. |
Nucleic acid and corresponding protein called STEAP-1 useful in the treatment and detection of cancer
|
ATE346305T1
(en)
*
|
2001-09-24 |
2006-12-15 |
Gruenenthal Gmbh |
SCREENING PROCEDURE FOR VARIOUS INDICATIONS USING BNPI AND/OR DNPI
|
US7265214B2
(en)
*
|
2001-10-19 |
2007-09-04 |
Rigel Pharmaceuticals, Inc. |
Germinal center kinase proteins, compositions and methods of use
|
WO2003038040A2
(en)
*
|
2001-10-29 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
32235, a human aminotransferase family member and uses therefor
|
EP1440169A4
(en)
*
|
2001-10-31 |
2005-09-21 |
Millennium Pharm Inc |
Methods and compositions for the treatment and diagnosis of pain disorders using 57749
|
WO2003037253A2
(en)
|
2001-10-31 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
|
ATE364690T1
(en)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
|
WO2003047611A2
(en)
*
|
2001-12-04 |
2003-06-12 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Ptp10d, tec and edtp involved in triglycerid-metabolism
|
WO2003054153A2
(en)
*
|
2001-12-12 |
2003-07-03 |
University Of Cincinnati |
Apyrase polypeptides and nucleic acids encoding same
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
EP1458754B1
(en)
*
|
2001-12-18 |
2009-12-09 |
Endocube SAS |
Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
|
AU2003244347A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Takeda Chemical Industries, Ltd. |
Angiogenesis inhibitors
|
GB0205112D0
(en)
*
|
2002-03-05 |
2002-04-17 |
Pantherix Ltd |
Enzyme
|
WO2003076072A1
(en)
|
2002-03-11 |
2003-09-18 |
Japan Science And Technology Agency |
Practical chiral zirconium catalyst
|
DE10212397A1
(en)
|
2002-03-20 |
2003-10-16 |
Universitaetsklinikum Freiburg |
Repressor of skeletal muscle differentiation, nucleic acid coding for it and its use in diagnostics and therapy
|
US20050065082A1
(en)
*
|
2002-03-29 |
2005-03-24 |
Hirofumi Doi |
C-jun phosphorylation inhibitors
|
US20050202431A1
(en)
*
|
2002-04-01 |
2005-09-15 |
National Institute Of Advanced Industrial Science |
Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
|
US7538088B2
(en)
|
2002-04-26 |
2009-05-26 |
California Institute Of Technology |
Method for inhibiting angiogenesis by administration of the extracellular domain of D1-1 polypeptide
|
US7622443B2
(en)
|
2002-04-26 |
2009-11-24 |
California Institute Of Technology |
Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
|
DE10222845A1
(en)
*
|
2002-05-23 |
2003-12-04 |
Dresden Arzneimittel |
Cloning, expression and characterization of the overall sequence of phosphodiesterase 8B
|
WO2004003165A2
(en)
*
|
2002-06-28 |
2004-01-08 |
Imclone Systems Incorporated |
Novel polynucleotide and polypeptide sequences and uses thereof
|
AU2003260312A1
(en)
*
|
2002-07-19 |
2004-02-09 |
Cellzome Ag |
Protein complexes of the TIP60 transcriptional activator protein
|
US7135556B2
(en)
|
2002-07-19 |
2006-11-14 |
Schering Corporation |
NPC1L1 (NPC3) and methods of use thereof
|
JP2004290170A
(en)
*
|
2002-08-02 |
2004-10-21 |
Takeda Chem Ind Ltd |
Use of gene associated with disease
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
US20080213166A1
(en)
*
|
2002-11-20 |
2008-09-04 |
Biogen Idec Inc. |
Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
|
EP1572736A2
(en)
*
|
2002-12-10 |
2005-09-14 |
Endocube SAS |
Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
|
JP4140951B2
(en)
*
|
2002-12-18 |
2008-08-27 |
独立行政法人科学技術振興機構 |
Transcriptional regulator ZHX3
|
DE60335216D1
(en)
*
|
2002-12-29 |
2011-01-13 |
Nissan Chemical Ind Ltd |
ADIPONEKTIN RECEPTOR AND GENERATING ENCODER
|
WO2004065551A2
(en)
*
|
2003-01-21 |
2004-08-05 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof
|
KR20050105448A
(en)
*
|
2003-02-03 |
2005-11-04 |
도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 |
Regeneration and neogenesis of retinal visual cell with otx2 gene
|
EP1599498A2
(en)
*
|
2003-03-03 |
2005-11-30 |
Genentech, Inc. |
Compositions and methods for the treatment of systemic lupus erythematosis
|
CA2522994C
(en)
*
|
2003-04-30 |
2012-09-25 |
Agensys, Inc. |
Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
|
WO2004104218A1
(en)
*
|
2003-05-23 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
|
WO2005023855A2
(en)
*
|
2003-09-10 |
2005-03-17 |
Friedrich-Alexander-Uni- Versitatet Erlangen- Nuernberg |
K203 gene and protein
|
WO2005030953A1
(en)
*
|
2003-09-30 |
2005-04-07 |
Daiichi Pharmaceutical Co., Ltd. |
Tetrahydrofolate synthase gene
|
WO2005059504A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
|
US7901893B2
(en)
|
2004-01-16 |
2011-03-08 |
Merck Sharp & Dohme Corp. |
NPC1L1 (NPC3) and methods of identifying ligands thereof
|
EP1723227A4
(en)
*
|
2004-02-10 |
2007-09-19 |
Dartmouth College |
Nicotinamide riboside kinase compositions and methods for using the same
|
US9233245B2
(en)
|
2004-02-20 |
2016-01-12 |
Brainsgate Ltd. |
SPG stimulation
|
US8010189B2
(en)
|
2004-02-20 |
2011-08-30 |
Brainsgate Ltd. |
SPG stimulation for treating complications of subarachnoid hemorrhage
|
US8055347B2
(en)
|
2005-08-19 |
2011-11-08 |
Brainsgate Ltd. |
Stimulation for treating brain events and other conditions
|
CA2559211A1
(en)
|
2004-03-19 |
2005-09-29 |
Yale University |
Detection, isolation and uses of renalase (monoamine oxidase c)
|
US9845344B2
(en)
*
|
2004-03-30 |
2017-12-19 |
Hoba Therapeutics Aps |
Therapeutic use of a growth factor, NsG33
|
US20050222040A1
(en)
*
|
2004-04-05 |
2005-10-06 |
Blm Group, Inc. |
Vertebrate peptide modulators of lipid metabolism
|
AU2004319915B9
(en)
|
2004-04-22 |
2011-12-22 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
ES2414460T3
(en)
|
2004-08-04 |
2013-07-19 |
Amgen Inc. |
Antibodies for Dkk-1
|
WO2006069592A2
(en)
*
|
2004-12-31 |
2006-07-06 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Method for diagnosing an/or predicting preeclampsia and/or related disorders
|
FI20050011A
(en)
*
|
2005-01-05 |
2006-07-06 |
Jurilab Ltd Oy |
Procedure and test package to detect the risk of type 2 diabetes mellitus
|
WO2006074914A2
(en)
*
|
2005-01-13 |
2006-07-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Human rna helicase and therapeutic uses thereof
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
JP2009516693A
(en)
|
2005-11-21 |
2009-04-23 |
イエール ユニバーシティ |
Method for regulating Renalase (monoamine oxidase C)
|
US9206242B2
(en)
*
|
2005-11-22 |
2015-12-08 |
National University Corporation Nagoya University |
Application of actin-binding protein to disease associated with cell motility
|
US7910698B2
(en)
|
2006-02-24 |
2011-03-22 |
Schering Corporation |
NPC1L1 orthologues
|
ES2636089T3
(en)
|
2006-10-27 |
2017-10-05 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses for them
|
WO2008136541A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Snu R&Db Foundation |
Angiogenesis inhibitor comprising meteorin as an active ingredient
|
DK2173379T3
(en)
|
2007-07-02 |
2015-12-07 |
Oncomed Pharm Inc |
Compositions and methods for treatment and diagnosis of cancer
|
US20100209436A1
(en)
*
|
2007-07-03 |
2010-08-19 |
Andreas Reichert |
Method for treating diseases related to mitochondrial dysfunction
|
EP2178551A4
(en)
*
|
2007-07-24 |
2010-07-21 |
Sanare Invest As |
Novel peptides with anti-tumor activity
|
US8551779B2
(en)
|
2007-12-28 |
2013-10-08 |
Novo Nordisk A/S |
DDR1-mediated cell purification of pancreatic endocrine cells through their progenitors
|
WO2010009732A1
(en)
|
2008-07-24 |
2010-01-28 |
Nsgene A/S |
Therapeutic use of a growth factor, metrnl
|
ES2742251T3
(en)
|
2009-03-16 |
2020-02-13 |
Pangu Biopharma Ltd |
Compositions and methods comprising variants of histidyl tarn synthetase splicing that have non-canonical biological activities
|
AR075989A1
(en)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
ANTIBODY DKK -1 (DICKKOPF-1) HUMAN DESIGNED BY ENGINEERING
|
US8815779B2
(en)
|
2009-09-16 |
2014-08-26 |
SwitchGear Genomics, Inc. |
Transcription biomarkers of biological responses and methods
|
EP3002297B1
(en)
|
2009-11-30 |
2020-04-08 |
F. Hoffmann-La Roche AG |
Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211)
|
US9127268B2
(en)
|
2009-12-11 |
2015-09-08 |
Atyr Pharma, Inc. |
Aminoacyl tRNA synthetases for modulating inflammation
|
CA2798301C
(en)
|
2010-05-04 |
2020-09-15 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
|
WO2012021249A2
(en)
|
2010-07-12 |
2012-02-16 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
|
ES2584068T3
(en)
|
2010-10-01 |
2016-09-23 |
Nsgene A/S |
Use of meteorine to treat allodynia, hyperalgesia, spontaneous pain and phantom pain
|
EP2731625B1
(en)
|
2011-07-15 |
2018-04-18 |
OncoMed Pharmaceuticals, Inc. |
Rspo binding agents and uses thereof
|
WO2013034157A1
(en)
|
2011-09-05 |
2013-03-14 |
Nsgene A/S |
Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
|
AU2013221317B2
(en)
|
2012-02-16 |
2017-07-06 |
Pangu Biopharma Limited |
Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
|
CA2878868A1
(en)
|
2012-07-13 |
2014-01-16 |
Austin L. Gurney |
Rspo3 binding agents and uses thereof
|
EP2742935A1
(en)
*
|
2012-12-14 |
2014-06-18 |
Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH |
SERF2 for the treatment of atrophy and for increasing cell growth
|
DK3460054T3
(en)
|
2013-03-15 |
2021-01-18 |
Atyr Pharma Inc |
Histidyl-tRNA-synthetase-Fc conjugates
|
EP2878335B1
(en)
|
2013-11-10 |
2018-01-03 |
Brainsgate Ltd. |
Implant and delivery system for neural stimulator
|
WO2016044295A1
(en)
|
2014-09-16 |
2016-03-24 |
Oncomed Pharmaceuticals, Inc. |
Treatment of fibrotic diseases
|
US10271907B2
(en)
|
2015-05-13 |
2019-04-30 |
Brainsgate Ltd. |
Implant and delivery system for neural stimulator
|
CN110049769A
(en)
|
2016-12-04 |
2019-07-23 |
阿拉维·霍拉萨尼·默哈达姆·马塞尔·维克托 |
Treatment and mitochondria stress relevant disease method
|
WO2018176065A1
(en)
*
|
2017-03-23 |
2018-09-27 |
Oregon State University |
Therapeutic compositions and methods for treatment of muscle wasting diseases
|
JP7247101B2
(en)
|
2017-04-03 |
2023-03-28 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Antibody that binds to STEAP-1
|
AU2018256435A1
(en)
|
2017-04-20 |
2019-11-07 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
CN110910960B
(en)
*
|
2019-11-30 |
2022-07-08 |
浙江天科高新技术发展有限公司 |
Acinetobacter baumannii molecular serotype rapid analysis method
|
KR20230136597A
(en)
*
|
2020-12-08 |
2023-09-26 |
이매진 파마 엘엘씨 |
Compositions and methods for wound treatment
|